Phase 1B study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): Updated results from the KEYNOTE-013 trial Meeting Abstract
| Authors: | Zinzani, P.; Ribrag, V.; Moskowitz, C. H.; Michot, J.; Kuruvilla, J.; Bartlett, N.; Balakumaran, A.; Chatterjee, A.; Chlosta, S.; Shipp, M. A.; Armand, P. |
| Abstract Title: | Phase 1B study of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma (rrPMBCL): Updated results from the KEYNOTE-013 trial |
| Meeting Title: | 14th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 Jun 14-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-06-07 |
| Start Page: | 189 |
| End Page: | 190 |
| Language: | English |
| ACCESSION: | 123459796 |
| DOI: | 10.1002/hon.2438_50 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 190 -- Accession Number: 123459796 -- Entry Date: In Process -- Revision Date: 20170608 -- Publication Type: Article -- Supplement Title: Jun2017 Supplement -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
